Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ARGATROBAN for Deep vein thrombosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 18 adverse event reports in the FDA FAERS database where ARGATROBAN was used for Deep vein thrombosis.

Most Reported Side Effects for ARGATROBAN

Side Effect Reports % Deaths Hosp.
Drug ineffective 109 16.0% 12 63
Heparin-induced thrombocytopenia 91 13.3% 21 58
Off label use 55 8.1% 10 21
Haemorrhage 45 6.6% 19 10
Cerebral infarction 35 5.1% 8 12
Disseminated intravascular coagulation 35 5.1% 10 21
Pulmonary embolism 30 4.4% 8 16
Deep vein thrombosis 29 4.3% 1 15
Thrombocytopenia 29 4.3% 8 19
Thrombosis 25 3.7% 9 11
Cerebral haemorrhage 22 3.2% 12 9
Gastrointestinal haemorrhage 20 2.9% 3 10
Multiple organ dysfunction syndrome 19 2.8% 13 10
Coagulopathy 17 2.5% 9 5
Subarachnoid haemorrhage 17 2.5% 9 9

Other Indications for ARGATROBAN

Heparin-induced thrombocytopenia (169) Anticoagulant therapy (134) Product used for unknown indication (70) Cerebral infarction (34) Pulmonary embolism (23) Thrombosis prophylaxis (23) Thrombosis (17) Thrombocytopenia (16) Ischaemic stroke (14) Thrombotic cerebral infarction (12)

Other Drugs Used for Deep vein thrombosis

RIVAROXABAN (17,913) APIXABAN (6,535) WARFARIN (2,294) ENOXAPARIN (1,209) DABIGATRAN ETEXILATE (668) HEPARIN (603) XARELTO (506) EDOXABAN (404) ASPIRIN (356) DALTEPARIN (191)

Related Pages

ARGATROBAN Full Profile All Deep vein thrombosis Drugs ARGATROBAN Demographics ARGATROBAN Timeline